OXC

OXONIC ACID

Created:	2003-10-10
Last modified:	2011-06-04

Find Related PDB Entry
2 entries where OXC is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	16
Chiral Atom Count	0
Bond Count	16
Aromatic Bond Count	0

2D diagram of OXC

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	OXONIC ACID
Systematic Name (OpenEye OEToolkits)	4,6-dioxo-1,3,5-triazinane-2-carboxylic acid
Formula	C₄ H₅ N₃ O₄
Molecular Weight	159.1
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C1NC(C(=O)O)NC(=O)N1
SMILES	CACTVS	3.341	OC(=O)C1NC(=O)NC(=O)N1
SMILES	OpenEye OEToolkits	1.5.0	C1(NC(=O)NC(=O)N1)C(=O)O
Canonical SMILES	CACTVS	3.341	OC(=O)C1NC(=O)NC(=O)N1
Canonical SMILES	OpenEye OEToolkits	1.5.0	C1(NC(=O)NC(=O)N1)C(=O)O
InChI	InChI	1.03	InChI=1S/C4H5N3O4/c8-2(9)1-5-3(10)7-4(11)6-1/h1H,(H,8,9)(H3,5,6,7,10,11)
InChIKey	InChI	1.03	IRFZLMWJJPULRF-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank ID	DB03209
Name	Oteracil
Groups	approved
Description	Oteracil is an adjunct to antineoplastic therapy, used to reduce the toxic side effects associated with chemotherapy. Approved by the European Medicines Agency (EMA) in March 2011, Oteracil is available in combination with [DB09257] and [DB09256] within the commercially available product "Teysuno". The main active ingredient in Teysuno is [DB09256], a pro-drug of [DB00544] (5-FU), which is a cytotoxic anti-metabolite drug that acts on rapidly dividing cancer cells. By mimicking a class of compounds called "pyrimidines" that are essential components of RNA and DNA, 5-FU is able to insert itself into strands of DNA and RNA, thereby halting the replication process necessary for continued cancer growth. Oteracil's main role within Teysuno is to reduce the activity of 5-FU within normal gastrointestinal mucosa, and therefore reduce's gastrointestinal toxicity [L933]. It functions by blocking the enzyme orotate phosphoribosyltransferase (OPRT), which is involved in the production of 5-FU.
Synonyms	Oxonate Oteracil potassium Allantoxanic acid Oxonic Acid Oteracil 5-azaorotic acid
Brand Names	Teysuno
Indication	Oteracil is used as an adjunct to antineoplastic therapy. When used within the product Teysuno, oteracil is indicated for the treatment of adults with advanced gastric (stomach) cancer when given in combination with cisplatin.
Categories	Triazines
CAS number	937-13-3

Related Resource References

Resource Name	Reference
PubChem	100562
ChEBI	CHEBI:44725

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.